These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32489326)

  • 1. LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis.
    Liu Y; Guo R; Qiao Y; Han L; Liu M
    Cancer Cell Int; 2020; 20():190. PubMed ID: 32489326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Non-Coding RNA NNT-AS1 Contributes to Cisplatin Resistance via miR-1236-3p/ATG7 Axis in Lung Cancer Cells.
    Wang H; Guo M; Ding D; Yang F; Chen Z
    Onco Targets Ther; 2020; 13():3641-3652. PubMed ID: 32431515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
    Cai Y; Dong ZY; Wang JY
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of
    Tian J; Li Z; Jiang Y; Gu W; Kong E; Hao Q; Kong B; Sun L
    Rejuvenation Res; 2022 Oct; 25(5):243-252. PubMed ID: 36039935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA OIP5-AS1 contributes to cisplatin resistance of oral squamous cell carcinoma through the miR-27b-3p/TRIM14 axis.
    Xiao Z; Li J; Jin Q; Liu D
    Exp Ther Med; 2021 Apr; 21(4):408. PubMed ID: 33692839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of microRNA-4739 in enhancing cisplatin chemosensitivity by negative regulation of RHBDD2 in human cervical cancer cells.
    Li Y; Zhou Z; Qu J; Gong P; Wei Y; Sun Y
    Cell Mol Biol Lett; 2024 Jan; 29(1):20. PubMed ID: 38267862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-96-5p regulates cervical cancer cell resistance to cisplatin by inhibiting lncRNA TRIM52-AS1 and promoting IGF2BP2.
    Wu EY; Huang LP; Bao JH
    Kaohsiung J Med Sci; 2022 Dec; 38(12):1178-1189. PubMed ID: 36354205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA NNT-AS1 promotes lung squamous cell carcinoma progression by regulating the miR-22/FOXM1 axis.
    Ma J; Qi G; Li L
    Cell Mol Biol Lett; 2020; 25():34. PubMed ID: 32514270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis.
    Huang JW; Luo XY; Li ZH; Lang BP
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):238-248. PubMed ID: 31957837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis.
    Zeng Z; Zhao G; Zhu H; Nie L; He L; Liu J; Li R; Xiao S; Hua G
    Cancer Cell Int; 2020; 20():350. PubMed ID: 32742197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
    Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
    Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
    Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of ZNF205-AS1/EGR4 positive feedback loop attenuates cisplatin resistance of non-small cell lung cancer cells via targeting miR-138-5p/OCT4 pathway.
    Li H; Jin Y; Zhu Y; Shen B; Xu Y
    J Thorac Dis; 2024 Jan; 16(1):296-310. PubMed ID: 38410545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown Of lncRNA NCK-AS1 Regulates Cisplatin Resistance Through Modulating miR-137 In Osteosarcoma Cells.
    Cheng Y; Shen X; Zheng M; Zou G; Shen Y
    Onco Targets Ther; 2019; 12():11057-11068. PubMed ID: 31908475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA FGD5-AS1 contributes to cisplatin resistance in hepatocellular carcinoma via sponging microRNA-153-3p by upregulating Twinfilin Actin Binding Protein 1 (TWF1).
    Yang Y; Shi L; Zhang D; Wu D; An Y; Zhang Y; Chen X
    Bioengineered; 2021 Dec; 12(1):6713-6723. PubMed ID: 34519634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA
    Wu D; Zhang T; Wang J; Zhou J; Pan H; Qu P
    Aging (Albany NY); 2019 Dec; 11(24):12624-12640. PubMed ID: 31848324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HAND2-AS1 inhibits 5-fluorouracil resistance by modulating miR-20a/PDCD4 axis in colorectal cancer.
    Jiang Z; Li L; Hou Z; Liu W; Wang H; Zhou T; Li Y; Chen S
    Cell Signal; 2020 Feb; 66():109483. PubMed ID: 31760170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircRNA circ_0005273 contributes to the cisplatin resistance of cervical cancer cells by sponging miR-133b.
    Wu L; Gao J; Liu S; Jia Y; Li C; Duan L
    J Obstet Gynaecol; 2022 Oct; 42(7):3086-3093. PubMed ID: 35861544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.